Cardiometabolic Disorders News

The benefits of gender-affirming hormone therapy outweigh the risks for transgender women of all ages as well as those with comorbidities, according to a speaker at the 2022 North American Menopause Society annual meeting.

SGLT2 inhibition in older patients with type 2 diabetes was associated with lower risk for incident atrial fibrillation compared with dipeptidyl peptidase IV inhibition or GLP-1 receptor agonist treatment, researchers reported.

Women with gestational diabetes have increased risks for overall and specific types of cardiovascular and cerebrovascular diseases, whether or not they go on to develop type 2 diabetes, according to study data published in The BMJ.

Among adults with acromegaly, concomitant type 2 diabetes was associated with increased risks for overall mortality and for cardiovascular mortality and morbidity, researchers reported in The Journal of Clinical Endocrinology & Metabolism.

Regional differences in hormonal and metabolic profiles in polycystic ovary syndrome exist between women in Alabama, who are more likely to have hirsutism, and those California, who are more likely to have hyperandrogenemia.

Healio is continuing its partnership with the Cardiometabolic Health Congress in support of the 17th Annual Cardiometabolic Health Congress: The Present and Future of Cardiometabolic Health in Boston.

Exposure to moderate or high levels of some phthalates is associated with lower levels of sex hormone-binding globulin and a higher risk for obesity among women, according to study data.

Weight loss after bariatric surgery may drive marked improvements in cardiac structure and function due to reductions in visceral fat, including left ventricular reverse remodeling and reduced ventricular interaction, researchers reported.

A low-carbohydrate vegan diet was associated with weight and BP reductions that were similar to those seen with a vegetarian diet, while possessing a greater potential reduction in greenhouse gas emissions, a study reported.

In an observational study of participants from the MESA cohort, statin use was not associated with incident diabetes, researchers reported in The American Journal of Cardiology.